+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Medical Device Outsourcing Market Size, Share & Trends Analysis Report by Service (Quality Assurance, Regulatory Affairs Services), by Application (Cardiology, Diagnostic Imaging, Orthopedic), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4621725
  • Report
  • February 2020
  • Region: Global
  • 100 pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Accell Clinical Research
  • Covance, Inc.
  • Flex Ltd.
  • Intertek Group Plc
  • Medpace
  • Promedica International
  • MORE
The global medical device outsourcing market size is expected to reach USD 231.2 billion by 2027, expanding at a CAGR of 10.4%. The growing incidence of chronic diseases is one of the major factors contributing to market growth. Regulatory bodies are mainly focusing on the quality of the healthcare devices provided to the public. Hence this is encouraging various players in the market to offer various services like regulatory consulting. For example, the European Medical Device Regulation undertake special spontaneous inspection of outsourced products to test the quality as well as conformity with standards.

The importance of regulatory compliance is expected to boost the growth of consulting services such as remediation, compliance, and quality management systems (QMS), thereby contributing to market growth. Whereas, the budget scrutiny in developed countries, pricing pressure, and changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by the original equipment manufacturers (OEM). These factors are expected to boost medical device outsourcing to emerging countries like India and China.

In addition, increasing difficulties in product engineering along with new entrants in the market are anticipated to shape the future of the market for medical device outsourcing. Whereas rising prevalence of chronic diseases is boosting the demand for medical devices. This, in turn, is helping the market to grow during the forecast period. Various companies are shifting their focus to research and development of new medical devices and are therefore outsourcing these activities to launch efficient medical devices in the market.

Further key findings from the report suggest:
  • Contract manufacturing accounted for the largest share in service segment in 2019, due to increasing trend of outsourcing, especially in emerging countries
  • The quality assurance segment is expected to witness the highest CAGR over the forecast period
  • Asia Pacific dominated the medical device outsourcing market with the largest share in 2019. Increasing demand for new technologies along with advanced healthcare infrastructure are likely to facilitate the dominance of this region in the market for medical device outsourcing during the forecast period
  • North America is projected to witness the fastest growth during the forecast period owing to increasing prevalence of chronic diseases in this region
  • Some of the key market players are SGS SA, TOXIKON, INC., EUROFINS SCIENTIFIC, and PACE ANALYTICAL SERVICES, LLC.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Accell Clinical Research
  • Covance, Inc.
  • Flex Ltd.
  • Intertek Group Plc
  • Medpace
  • Promedica International
  • MORE
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Application
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1: Understanding the market dynamics
1.9.2. Objective 2: Understanding the market estimates and forecasts
1.9.3. Objective 3: Understanding the attributes such as strategy framework, competitor categorization
1.9.4. Objective 4: Understanding the key product and application scopes to conclude on the market size

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Medical Device Outsourcing Market Variables, Trends & Scope
3.1. Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Product Pipeline Analysis, by Service
3.4. Market Dynamics
3.4.1. Market Driver Analysis
3.4.1.1. Changing regulatory landscape
3.4.1.2. Increase in offshoring medical device manufacturing to emerging countries
3.4.1.3. Rising demand for advanced products
3.4.1.4. Implementation of international standards by contract manufacturers
3.4.1.5. Rising price competition and requirement to reduce cost
3.4.1.6. Increasing complexity with respect to product design and engineering
3.4.2. Market Restraint Analysis
3.4.2.1. Compliance issues while outsourcing
3.4.2.2. Changing scenarios in developing countries
3.4.2.3. Regulatory and legal compliance
3.4.2.4. Contractual obligation
3.4.3. Industry Challenges
3.4.3.1. Managing the relationships
3.5. Medical Device Outsourcing: Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier Power
3.5.1.2. Buyer Power
3.5.1.3. Substitution Threat
3.5.1.4. Threat from new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political Landscape
3.5.2.2. Environmental Landscape
3.5.2.3. Social Landscape
3.5.2.4. Technology Landscape
3.5.2.5. Legal Landscape
3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Medical Device Outsourcing Market : Segment Analysis, by Services, 2016 - 2027 (USD Million)
4.1. Definitions & Scope
4.2. Product market share analysis, 2019 & 2027
4.3. Segment Dashboard
4.4. Global medical device outsourcing Market, by services, 2016 to 2027
4.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027for the following
4.5.1. Quality Assurance
4.5.2. Regulatory Affairs Services
4.5.2.1 Clinical trials applications and product registrations
4.5.2.2 Regulatory writing and publishing
4.5.2.3 Legal representation
4.5.2.4 Other
4.5.3. Product Design and Development Services
4.5.3.1 Designing & engineering
4.5.3.2 Machining
4.5.3.3 Molding
4.5.3.4 Packaging
4.5.4. Product Testing & Sterilization Services
4.5.5. Product Implementation Services
4.5.6. Product Upgrade Services
4.5.7. Product Maintenance Services
4.5.8. Contract Manufacturing
4.5.8.1 Accessories manufacturing
4.5.8.2 Assembly manufacturing
4.5.8.3 Component manufacturing
4.5.8.4 Device manufacturing

Chapter 5. Medical Device Outsourcing Market : Segment Analysis, By Application, 2016 - 2027 (USD Million)
5.1. Definitions & Scope
5.2. Application market share analysis, 2019 & 2027
5.3. Segment Dashboard
5.4. Global medical device outsourcing market, by application, 2016 to 2027
5.5. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following
5.5.1. Cardiology
5.5.2.1 Class I
5.5.2.2 Class II
5.5.2.3 Class III
5.5.2. Diagnostic imaging
5.5.2.1 Class I
5.5.2.2 Class II
5.5.2.3 Class III
5.5.3. Orthopedic
5.5.3.1 Class I
5.5.3.2 Class II
5.5.3.3 Class III
5.5.4. IVD
5.5.4.1 Class I
5.5.4.2 Class II
5.5.4.3 Class III
5.5.5. Ophthalmic
5.5.5.1 Class I
5.5.5.2 Class II
5.5.5.3 Class III
5.5.6. General and plastic surgery
5.5.6.1 Class I
5.5.6.2 Class II
5.5.6.3 Class III
5.5.7. Drug delivery
5.5.7.1 Class I
5.5.7.2 Class II
5.5.7.3 Class III
5.5.8. Dental
5.5.8.1 Class I
5.5.8.2 Class II
5.5.8.3 Class III
5.5.9. Endoscopy
5.5.9.1 Class I
5.5.9.2 Class II
5.5.9.3 Class III
5.5.10. Diabetes care
5.5.10.1 Class I
5.5.10.2 Class II
5.5.10.3 Class III
5.5.11. Others
5.5.11.1 Class I
5.5.11.2 Class II
5.5.11.3 Class III

Chapter 6. Medical Device Outsourcing Market : Regional Market Analysis, By Services, 2016 - 2027 (USD Million)
6.1. Definitions & Scope
6.2. Regional Market Share Analysis, 2019 & 2027
6.3. Regional Market Dashboard
6.4. Regional Market Snapshot
6.5. Regional Market Share, 2018
6.6. Market Size, & Forecasts, and Trend Analysis, 2016 to 2027:
6.7. North America
6.7.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.7.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.3. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.7.4. U.S.
6.7.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.4.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.7.5. Canada
6.7.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.7.5.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8. Europe
6.8.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.8.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.3. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.4. Germany
6.8.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.4.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.5. U.K.
6.8.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.5.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.6. France
6.8.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.6.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.7. Italy
6.8.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.7.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.8. Spain
6.8.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.8.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.9. Netherlands
6.8.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.9.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.10. Belgium
6.8.10.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.10.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.11. Switzerland
6.8.11.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.11.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.12. Russia
6.8.12.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.12.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.8.13. Sweden
6.8.13.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.8.13.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9. Asia Pacific
6.9.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.9.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.3. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.4. China
6.9.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.4.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.5. Japan
6.9.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.5.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.6. India
6.9.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.6.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.7. Australia
6.9.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.7.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.8. South Korea
6.9.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.8.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.9. Malaysia
6.9.9.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.9.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.10. Indonesia
6.9.10.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.10.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.11. Singapore
6.9.11.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.11.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.12. Philippines
6.9.12.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.12.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.9.13. Thailand
6.9.13.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.9.13.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10. Latin America
6.10.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.10.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.3. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10.4. Brazil
6.10.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.4.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10.5. Mexico
6.10.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.5.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10.6. Argentina
6.10.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.6.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10.7. Colombia
6.10.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.7.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.10.8. Chile
6.10.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.10.8.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11. Middle East and Africa
6.11.1. Market estimates and forecast, by country, 2016 - 2027 (USD Million)
6.11.2. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.3. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11.4. South Africa
6.11.4.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.4.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11.5. Saudi Arabia
6.11.5.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.5.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11.6. UAE
6.11.6.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.6.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11.7. Israel
6.11.7.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.7.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)
6.11.8. Egypt
6.11.8.1. Market estimates and forecast, by Services, 2016 - 2027 (USD Million)
6.11.8.2. Market estimates and forecast, by Application, 2016 - 2027 (USD Million)

Chapter 7. Medical Device Outsourcing Market - Competitive Analysis
7.1. Key companies profiled
7.1.1. SGS SA
7.1.1.1. Company Overview
7.1.1.2. Financial Performance
7.1.1.3. Product Benchmarking
7.1.1.4. Strategic Initiatives
7.1.2. TOXIKON, INC.
7.1.2.1. Company Overview
7.1.2.2. Financial Performance
7.1.2.3. Product Benchmarking
7.1.2.4. Strategic Initiatives
7.1.3. EUROFINS SCIENTIFIC
7.1.3.1. Company Overview
7.1.3.2. Financial Performance
7.1.3.3. Product Benchmarking
7.1.3.4. Strategic Initiatives
7.1.4. PACE ANALYTICAL SERVICES LLC.
7.1.4.1. Company Overview
7.1.4.2. Financial Performance
7.1.4.3. Product Benchmarking
7.1.4.4. Strategic Initiatives
7.1.5. INTERTEK GROUP PLC
7.1.5.1. Company Overview
7.1.5.2. Financial Performance
7.1.5.3. Product Benchmarking
7.1.5.4. Strategic Initiatives
7.1.6. WUXI APPTEC
7.1.6.1. Company Overview
7.1.6.2. Financial Performance
7.1.6.3. Product Benchmarking
7.1.6.4. Strategic Initiatives
7.1.7. NORTH AMERICAN SCIENCE ASSOCIATES, INC.
7.1.7.1. Company Overview
7.1.7.2. Financial Performance
7.1.7.3. Product Benchmarking
7.1.7.4. Strategic Initiatives
7.1.8. TÜV SÜD AG
7.1.8.1. Company Overview
7.1.8.2. Financial Performance
7.1.8.3. Product Benchmarking
7.1.8.4. Strategic Initiatives
7.1.9. AMERICAN PRECLINICAL SERVICES
7.1.9.1. Company Overview
7.1.9.2. Financial Performance
7.1.9.3. Product Benchmarking
7.1.9.4. Strategic Initiatives
7.1.10. STERIGENICS INTERNATIONAL LLC
7.1.10.1. Company Overview
7.1.10.2. Financial Performance
7.1.10.3. Product Benchmarking
7.1.10.4. Strategic Initiatives
7.1.11. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
7.1.11.1. Company Overview
7.1.11.2. Financial Performance
7.1.11.3. Product Benchmarking
7.1.11.4. Strategic Initiatives
7.1.12. MEDICAL DEVICE TESTING SERVICES
7.1.12.1. Company Overview
7.1.12.2. Financial Performance
7.1.12.3. Product Benchmarking
7.1.12.4. Strategic Initiatives
7.1.13. RJR CONSULTING, INC
7.1.13.1. Company Overview
7.1.13.2. Financial Performance
7.1.13.3. Product Benchmarking
7.1.13.4. Strategic Initiatives
7.1.14. MANDALA INTERNATIONAL.
7.1.14.1. Company Overview
7.1.14.2. Financial Performance
7.1.14.3. Product Benchmarking
7.1.14.4. Strategic Initiatives
7.1.15. MAPI GROUP
7.1.15.1. Company Overview
7.1.15.2. Financial Performance
7.1.15.3. Product Benchmarking
7.1.15.4. Strategic Initiatives
7.1.16. FREYR
7.1.16.1. Company Overview
7.1.16.2. Financial Performance
7.1.16.3. Product Benchmarking
7.1.16.4. Strategic Initiatives
7.1.17. GLOBAL REGULATORY PARTNERS-LLC
7.1.17.1. Company Overview
7.1.17.2. Financial Performance
7.1.17.3. Product Benchmarking
7.1.17.4. Strategic Initiatives
7.1.18. PAREXEL INTERNATIONAL CORPORATION
7.1.18.1. Company Overview
7.1.18.2. Financial Performance
7.1.18.3. Product Benchmarking
7.1.18.4. Strategic Initiatives
7.1.19. EMERGO
7.1.19.1. Company Overview
7.1.19.2. Financial Performance
7.1.19.3. Product Benchmarking
7.1.19.4. Strategic Initiatives
7.1.20. BIOTEKNICA
7.1.20.1. Company Overview
7.1.20.2. Financial Performance
7.1.20.3. Product Benchmarking
7.1.20.4. Strategic Initiatives
7.1.21. ACCELL CLINICAL RESEARCH
7.1.21.1. Company Overview
7.1.21.2. Financial Performance
7.1.21.3. Product Benchmarking
7.1.21.4. Strategic Initiatives
7.1.22. GENPACT LTD.
7.1.22.1. Company Overview
7.1.22.2. Financial Performance
7.1.22.3. Product Benchmarking
7.1.22.4. Strategic Initiatives
7.1.23. CRITERIUM, INC.
7.1.23.1. Company Overview
7.1.23.2. Financial Performance
7.1.23.3. Product Benchmarking
7.1.23.4. Strategic Initiatives
7.1.24. PRA HEALTH SCIENCES
7.1.24.1. Company Overview
7.1.24.2. Financial Performance
7.1.24.3. Product Benchmarking
7.1.24.4. Strategic Initiatives
7.1.25. PROMEDICA INTERNATIONAL
7.1.25.1. Company Overview
7.1.25.2. Financial Performance
7.1.25.3. Product Benchmarking
7.1.25.4. Strategic Initiatives
7.1.26. MEDPACE
7.1.26.1. Company Overview
7.1.26.2. Financial Performance
7.1.26.3. Product Benchmarking
7.1.26.4. Strategic Initiatives
7.1.27. ICON PLC.
7.1.27.1. Company Overview
7.1.27.2. Financial Performance
7.1.27.3. Product Benchmarking
7.1.27.4. Strategic Initiatives
7.1.28. QUINTILESIMS
7.1.28.1. Company Overview
7.1.28.2. Financial Performance
7.1.28.3. Product Benchmarking
7.1.28.4. Strategic Initiatives
7.1.29. COVANCE, INC.
7.1.29.1. Company Overview
7.1.29.2. Financial Performance
7.1.29.3. Product Benchmarking
7.1.29.4. Strategic Initiatives
7.1.30. INTEGER HOLDINGS CORPORATION
7.1.30.1. Company Overview
7.1.30.2. Financial Performance
7.1.30.3. Product Benchmarking
7.1.30.4. Strategic Initiatives
7.1.31. TECOMET INC.
7.1.31.1. Company Overview
7.1.31.2. Financial Performance
7.1.31.3. Product Benchmarking
7.1.31.4. Strategic Initiatives
7.1.32. JABIL INC.
7.1.32.1. Company Overview
7.1.32.2. Financial Performance
7.1.32.3. Product Benchmarking
7.1.32.4. Strategic Initiatives
7.1.33. FLEX LTD.
7.1.33.1. Company Overview
7.1.33.2. Financial Performance
7.1.33.3. Product Benchmarking
7.1.33.4. Strategic Initiatives
7.1.34. CELESTICA INC.
7.1.34.1. Company Overview
7.1.34.2. Financial Performance
7.1.34.3. Product Benchmarking
7.1.34.4. Strategic Initiatives
7.1.35. SANMINA CORPORATION.
7.1.35.1. Company Overview
7.1.35.2. Financial Performance
7.1.35.3. Product Benchmarking
7.1.35.4. Strategic Initiatives
7.1.36. PLEXUS CORP.
7.1.36.1. Company Overview
7.1.36.2. Financial Performance
7.1.36.3. Product Benchmarking
7.1.36.4. Strategic Initiatives
7.1.37. PHILLIPS MEDISIZE
7.1.37.1. Company Overview
7.1.37.2. Financial Performance
7.1.37.3. Product Benchmarking
7.1.37.4. Strategic Initiatives
7.1.38. CANTEL MEDICAL CORP.
7.1.38.1. Company Overview
7.1.38.2. Financial Performance
7.1.38.3. Product Benchmarking
7.1.38.4. Strategic Initiatives
7.1.39. WEST PHARMACEUTICAL SERVICES, INC.
7.1.39.1. Company Overview
7.1.39.2. Financial Performance
7.1.39.3. Product Benchmarking
7.1.39.4. Strategic Initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
  • SGS SA
  • TOXIKON, INC.
  • EUROFINS SCIENTIFIC
  • PACE ANALYTICAL SERVICES LLC.
  • INTERTEK GROUP PLC
  • WUXI APPTEC
  • NORTH AMERICAN SCIENCE ASSOCIATES, INC.
  • TÜV SÜD AG
  • AMERICAN PRECLINICAL SERVICES
  • STERIGENICS INTERNATIONAL LLC
  • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
  • MEDICAL DEVICE TESTING SERVICES
  • RJR CONSULTING, INC
  • MANDALA INTERNATIONAL.
  • MAPI GROUP
  • FREYR
  • GLOBAL REGULATORY PARTNERS-LLC
  • PAREXEL INTERNATIONAL CORPORATION
  • EMERGO
  • BIOTEKNICA
  • ACCELL CLINICAL RESEARCH
  • GENPACT LTD.
  • CRITERIUM, INC.
  • PRA HEALTH SCIENCES
  • PROMEDICA INTERNATIONAL
  • MEDPACE
  • ICON PLC.
  • QUINTILESIMS
  • COVANCE, INC.
  • INTEGER HOLDINGS CORPORATION
  • TECOMET INC.
  • JABIL INC.
  • FLEX LTD.
  • CELESTICA INC.
  • SANMINA CORPORATION.
  • PLEXUS CORP.
  • PHILLIPS MEDISIZE
  • CANTEL MEDICAL CORP.
  • WEST PHARMACEUTICAL SERVICES, INC.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll